Pipeline
The Science
About us
Investors
News

Hit enter to search or ESC to close

Dr David Stamler Biotech Showcase Presentation

January 8, 2018 Kerry Rowe

Prana Biotechnology JPM investor presentation_updated

Post navigation

Prana meeting with investors at world’s largest healthcare conference in San Francisco

PBT434 poster presented at the 6th International Multiple System Atrophy Conference

Related Posts

Prana receives $4.8 million R&D Tax Incentive Cash Refund

October 30, 2016

Prana EGM and Conference Call Facility

March 27, 2019

Prana Biotechnology Investor Presentation

June 27, 2018

Recent Posts

Alterity CEO David Stamler presents to US investors at the HC Wainwright Global Life Science Conference
Alterity to present at the 7th International Congress of Multiple System Atrophy
Alterity Half Year Results and Investor Webcast Notification
Alterity announces funding from Michael J. Fox Foundation for ATH434 dose optimization for Parkinson’s disease clinical trials
Quarterly Cash Flow Report

Recent Comments

Archives

Archives

Categories

ASX Announcements
Investor Announcement

About us

We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases.
Improving lives.

Pipeline
The Science
About us
Investors
News

Careers
Privacy Policy

Copyright © Alterity Therapeutics. ABN 37 080 699 065